Promising data for biomarker-guided care in metastatic UCC. Could NECTIN4 RNA expression help refine patient selection for EV+pembro? The key next step: prospective validation and distinguishing predictive from prognostic value. #BladderCancer
🎯 Can we predict who benefits most from EV + pembrolizumab?
New @EUplatinum data show that higher pretreatment tumor NECTIN4 RNA expression is associated with better efficacy of first-line EV+pembrolizumab in metastatic urothelial cancer.
https://t.co/7TxjdPqF8H
A scientist who successfully treated her own breast cancer by injecting the tumour with lab-grown viruses has sparked discussion about the ethics of self-experimentation https://t.co/wnjBX1zWjH
Exciting news!
Our latest #UrologyCheatSheet is here, bringing together the key genital lesions caused by sexually transmitted infections. Dive into essential information and guidance for diagnosis and treatment
Thank you @ManuelAlonsoUro for this fantastic work!
@ROC_Urologia
Exciting findings by our PhD students! Preoperative MMP-7 levels in invasive urothelial bladder cancer show promising prognostic value. Higher levels associated with poor survival. Let's explore its potential for risk stratification. #BladderCancer
https://t.co/vW0bpMpku1
Mark your calendars. End of April 2023 in Vienna - the central European meeting from the central European Urology society. Big event great people. Research & teaching and networking, that makes a social impact. Put it on your calendars & come and join us!